Hui Ching Yu
Direttore Finanziario/CFO presso VECTORITE BIOMEDICAL INC.
Provenienza dei contatti di primo grado di Hui Ching Yu
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Other Transportation | 10 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Hui Ching Yu tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Tamkang | College/University | Undergraduate Degree | |
National Cheng Kung University | College/University | Graduate Degree | |
Ming Chi University of Technology | College/University | Undergraduate Degree | |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Graduate Degree | |
UWELL Biopharma, Inc.
UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Pharmaceuticals: Major | Chairman |
Statistiche
Distribuzione geografica
Taiwan | 5 |
Stati Uniti | 2 |
Settori
Consumer Services | 5 |
Health Technology | 2 |
Posizioni
Director/Board Member | 6 |
Independent Dir/Board Member | 3 |
Undergraduate Degree | 2 |
Graduate Degree | 2 |
Chairman | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Hui Ching Yu
- Connessioni Società